FierceBiotech 2025-12-09 ASH: J&J makes case for Tecvayli combo as an alternative to CAR-T in 2nd-line multiple myeloma
FierceBiotech 2025-12-09 Pfizer continues renewed obesity push with $150M upfront for Fosun unit's GLP-1 drug
FierceBiotech 2025-12-09 ASH: Exicure rebounds with phase 2 win, seeing 90% blood cell mobilization in myeloma
Endpoints News 2025-12-09 Stealthy biotech Sidera Bio raises $109M; Assembly's data for oral herpes drugs
Lonza News 2025-12-09 Lonza Group, Catalent, and Recipharm Lead the $12.5 Billion Inhaled Drugs Contract Manufacturing Market, 2025-2033: Insights by Service, Product, End-Use and Region - ResearchAndMarkets.com - The AI Journal
10x Genomics Blog 2025-12-09 NeurIPS 2025: Biology’s Transformer Moment - Genetic Engineering and Biotechnology News